Zobrazeno 1 - 10
of 222
pro vyhledávání: '"I.M. Hoepelman"'
Autor:
Patrick G.A. Oomen, Inez Bronsveld, Andy I.M. Hoepelman, Berend J. van Welzen, Tania Mudrikova
Publikováno v:
AIDS. 37:1263-1267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa9f04c2a1c06e90ade7c7db73eb5506
https://doi.org/10.1097/qad.0000000000003540
https://doi.org/10.1097/qad.0000000000003540
Autor:
Ingeborg E.A. Wijting, Ferdinand W.N.M. Wit, Casper Rokx, Eliane M.S. Leyten, Selwyn H. Lowe, Kees Brinkman, Wouter F.W. Bierman, Marjo E.E. van Kasteren, Anneloes M. Postma, Vera C.M. Bloemen, Ghariba Bouchtoubi, Andy I.M. Hoepelman, Marchina E. van der Ende, Peter Reiss, Bart J.A. Rijnders
Publikováno v:
EClinicalMedicine, Vol 17, Iss , Pp - (2019)
Background: Integrase inhibitors (INI) induce a rapid decline of HIV-RNA in plasma and CD4+ T-cell recovery in blood. Both characteristics are also associated with immune reconstitution inflammatory syndrome (IRIS). Whether the use of INI-containing
Externí odkaz:
https://doaj.org/article/b881048eacf14cc6a42ecceebb6e4f2c
Autor:
Patrick G.A. Oomen, Charlotte S. Hakkers, Joop E. Arends, Guido E.L. van der Berk, Pascal Pas, Andy I.M. Hoepelman, Berend J. van Welzen, Stefan du Plessis
Publikováno v:
AIDS Research and Human Retroviruses.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a22f462a34983d4c81417c927056ae87
https://doi.org/10.1089/aid.2022.0069
https://doi.org/10.1089/aid.2022.0069
Autor:
Faydra I. Lieveld, Niels Swaans, Astrid M. Newsum, Cynthia K.Y. Ho, Janke Schinkel, Richard Molenkamp, Jan T.M. van der Meer, Joop E. Arends, Andy I.M. Hoepelman, Anne M.J. Wensing, Peter D. Siersema, Karel J. van Erpecum, Greet J. Boland
Publikováno v:
Annals of Hepatology, Vol 15, Iss 5, Pp 696-704 (2016)
Background and aim. Resistance-associated variants (RAVs) on the NS3 region of the hepatitis C virus (HCV) may be relevant for antiviral therapy, but data in human immunodeficiency virus (HIV) coinfected patients are scarce. We assessed frequencies o
Externí odkaz:
https://doaj.org/article/ef7f7c7b6ddf4c0f9a907447d000c29e
Autor:
J.J. Mark Haverkort, A.L.C. (Ben) Minderhoud, Jelte D.D. Wind, Luke P.H. Leenen, Andy I.M. Hoepelman, Pauline M. Ellerbroek
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 2, Pp 184-191 (2016)
The Major Incident Hospital of the University Medical Centre of Utrecht has a longstanding history of preparing for the management of highly pathogenic and infectious organisms. An assessment of the hospital’s preparations for an outbreak of viral
Externí odkaz:
https://doaj.org/article/4cdaeba952f649cb8522c08728fc18f9
Autor:
Thijs ten Doesschate, Anouk E. Muller, Irene A.M. Groenewegen, Kelly Hendriks, T.N. Platteel, Suzanne E. Geerlings, Andy I.M. Hoepelman, Evelien C. van der Hout, Cornelis H. van Werkhoven, Marc J. M. Bonten
Publikováno v:
Clinical Microbiology and Infection, 28(2), 248-254. Elsevier Ltd.
Clinical microbiology and infection. Elsevier Limited
Clinical microbiology and infection. Elsevier Limited
Objectives: Guidelines do not distinguish between 50 mg or 100 mg nitrofurantoin as daily prophylaxis for recurrent urinary tract infection (UTI), although 50 mg might have a better safety profile. Our objective was to compare the effectiveness and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0742482a1157ff35846f204fe454be
https://doi.org/10.1016/j.cmi.2021.05.048
https://doi.org/10.1016/j.cmi.2021.05.048
Autor:
Linda M. Kampschreur, Sandra Dekker, Julia C.J.P. Hagenaars, Peter J. Lestrade, Nicole H.M. Renders, Monique G.L. de Jager-Leclercq, Mirjam H.A. Hermans, Cornelis A.R. Groot, Rolf H.H. Groenwold, Andy I.M. Hoepelman, Peter C. Wever, Jan Jelrik Oosterheert
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 4, Pp 563-570 (2012)
Since 2007, the Netherlands has experienced a large Q fever outbreak. To identify and quantify risk factors for development of chronic Q fever after Coxiella burnetii infection, we performed a case–control study. Comorbidity, cardiovascular risk fa
Externí odkaz:
https://doaj.org/article/9f205da12f6d4c9fa7367bda2ed11656
Autor:
Soeradj Harkisoen, M.D., Joop E. Arends, Karel J. van Erpecum, Anneke van den Hoek, Andy I.M. Hoepelman
Publikováno v:
Annals of Hepatology, Vol 11, Iss 2, Pp 164-171 (2012)
Chronic hepatitis B has a variable course in disease activity with a risk of clinical complications like liver cirrhosis and hepatocellular carcinoma. As clinical symptoms present in a late stage of the disease, identification of risk factors is impo
Externí odkaz:
https://doaj.org/article/735aac10e4354d81bb6159aba0fa50d0
Autor:
F.W.N.M. Wit, Jesper M. Weehuizen, Annemarie M. J. Wensing, Tania Mudrikova, Andy I.M. Hoepelman
Publikováno v:
International Journal of Antimicrobial Agents, 54(2), 215. Elsevier
International journal of antimicrobial agents, 54(2), 215-222. Elsevier
International journal of antimicrobial agents, 54(2), 215-222. Elsevier
Since the registration of maraviroc (MVC) as an antiretroviral agent in 2008, only studies with a follow-up time of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75db440b97a1e7d68f12c61ef94f8061
https://doi.org/10.1016/j.ijantimicag.2019.02.018
https://doi.org/10.1016/j.ijantimicag.2019.02.018
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
Infection with the human immunodeficiency virus (HIV) is characterized by progressive depletion of CD4+ lymphocytes cells as a result of chronic immune activation. Next to the decreases in the number of CD4+ cells which leads to opportunistic infecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68dec771c1c5336a22e8e8d849ae1642
https://www.frontiersin.org/articles/10.3389/fimmu.2021.637910/full
https://www.frontiersin.org/articles/10.3389/fimmu.2021.637910/full